Inventor
OKHAMAFE AUGUSTUS O
US24 patents
⚠️ This page may combine multiple inventors who share the name “OKHAMAFE AUGUSTUS O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOMARIN PHARM INC
17 patentsUS7537923B2May 26, 2009
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
BIOMARIN PHARM INC49 citations95
US7790433B2Sep 7, 2010
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
BIOMARIN PHARM INC32 citations91
US10646550B2May 12, 2020
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
BIOMARIN PHARM INC7 citations82
USRE48267EOct 20, 2020
Variants of C-type natriuretic peptide
BIOMARIN PHARM INC2 citations72
US9907834B2Mar 6, 2018
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
BIOMARIN PHARM INC3 citations71
US9567572B2Feb 14, 2017
Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
BIOMARIN PHARM INC2 citations71
US9216178B2Dec 22, 2015
Dry blend formulation of tetrahydrobiopterin
BIOMARIN PHARM INC4 citations71
US11229687B2Jan 25, 2022
TPP-1 formulations and methods for treating CLN2 disease
BIOMARIN PHARM INC1 citations69
US10758598B2Sep 1, 2020
TPP-1 formulations and methods for treating CLN2 disease
BIOMARIN PHARM INC1 citations69
US10221408B2Mar 5, 2019
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
BIOMARIN PHARM INC3 citations69
US12514906B2Jan 6, 2026
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
BIOMARIN PHARM INC0 citations60
US12076372B2Sep 3, 2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
BIOMARIN PHARM INC0 citations60
US11911446B2Feb 27, 2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
BIOMARIN PHARM INC0 citations60
US11590204B2Feb 28, 2023
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
BIOMARIN PHARM INC0 citations60
US11505790B2Nov 22, 2022
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
BIOMARIN PHARM INC1 citations58
USRE46707EFeb 13, 2018
Variants of C-type natriuretic peptide
BIOMARIN PHARM INC0 citations51
US10279015B2May 7, 2019
TPP-1 formulations and methods for treating CLN2 disease
BIOMARIN PHARM INC0 citations45